Fig. 5.
Fig. 5. Mechanisms of p27KIP1 inactivation in aggressive B-cell lymphomas. / BCL6 and c-Myc could both contribute to p27KIP1inactivation through diverse mechanisms, leading to the increased activity of cyclin E–CDK2 complexes. Transcriptional repression ofp27KIP1, or induction of its proteasomal degradation, causes a decrease in p27KIP1 levels. Alternatively, in a subset of aggressive lymphomas featuring inactivation of p16INK4a and/or p21CIP1, p27KIP1 is sequestered in an inactive form by cyclin D–CDK4 complexes. K2, CDK2; K4, CDK4; E, cyclin E; D, cyclin D; Ub, ubiquitin.

Mechanisms of p27KIP1 inactivation in aggressive B-cell lymphomas.

BCL6 and c-Myc could both contribute to p27KIP1inactivation through diverse mechanisms, leading to the increased activity of cyclin E–CDK2 complexes. Transcriptional repression ofp27KIP1, or induction of its proteasomal degradation, causes a decrease in p27KIP1 levels. Alternatively, in a subset of aggressive lymphomas featuring inactivation of p16INK4a and/or p21CIP1, p27KIP1 is sequestered in an inactive form by cyclin D–CDK4 complexes. K2, CDK2; K4, CDK4; E, cyclin E; D, cyclin D; Ub, ubiquitin.

Close Modal

or Create an Account

Close Modal
Close Modal